Latest News about PFE
Recent news which mentions PFE
2 Dirt Cheap Dividend Stocks to Buy Right Now
July 27, 2023
From Motley Fool
From Benzinga
2 No-Brainer Cathie Wood Stocks to Buy Right Now
July 26, 2023
From Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
July 26, 2023
From Motley Fool
The ‘algos’ are the enemy: Machines created this stock market rally; eventually they will end it.
July 25, 2023
From MarketWatch
From Benzinga
Fentanyl Crisis In US: Biden Administration Contemplates Easing Sanctions on China's Forensic Institute
July 24, 2023
From Benzinga
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
July 24, 2023
From Benzinga
From Benzinga
GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval
July 24, 2023
From Benzinga
Pfizer To Terminate Development Pact With Syros Pharmaceuticals For Novel Therapies For Two Blood Disorders
July 24, 2023
From Benzinga
From MarketWatch
Dow Jones Leads Weekly Gains As Tesla, Netflix Sell-Offs Dent Nasdaq; Big Banks Show Resilience To Volatility
July 21, 2023
From Benzinga
Why Shares of BridgeBio Pharma Skyrocketed This Week
July 21, 2023
From Motley Fool
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
July 21, 2023
From MarketWatch
Tornado damage at Pfizer facility threatens to make critical drug-supply shortages even worse, experts say
July 20, 2023
From MarketWatch
From Motley Fool
From Benzinga
Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner'
July 20, 2023
From Benzinga
3 Blue-Chip Stocks Trading at a Valuation Gap
July 20, 2023
From InvestorPlace
Pfizer's GBS6 Vaccine Candidate Showcases Promising Protection for Infants Against Invasive GBS Disease: Phase 2 Study Reveals
July 20, 2023
Tickers
PFE
From Benzinga
From MarketWatch
Better Pharma Buy: Viatris vs. Pfizer
July 19, 2023
From Motley Fool
Pfizer, Flagship Pioneering Invest $100M In New Pipeline Of Innovative Drugs - What's On The Cards?
July 18, 2023
Tickers
PFE
From Benzinga
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.